Vantage Point

Vantage Point: The Next Generation of Drugs

Vantage Point: The Next Generation of Drugs

The next generation of drugs sees a number of market access challenges

Vantage Point: A Revolution in Research

Vantage Point: A Revolution in Research

A quiet revolution is underway in research to keep pace with changes in medical marketing

Vantage Point: The End of Illness

Vantage Point: The End of Illness

The best-selling book "The End of Illness" illustrates an exciting new way to think of healthcare—and healthcare marketing research

Vantage Point: The value of market research

Vantage Point: The value of market research

For the client-side market researcher, "doing more with less" is a mantra, if not a corporate way of life

Vantage Point: Qualitative Marketing Research

Vantage Point: Qualitative Marketing Research

For all the advances in technology and methodology, qualitative research cannot shed its history like its quant sibling

Vantage Point: Another look at marketing data

Vantage Point: Another look at marketing data

"External drivers" can have a significant impact on determining the answer to your marketing question

Vantage Point: Using real-world data

Vantage Point: Using real-world data

Marketing teams are not going to succeed in the future without a real understanding of the real world

Vantage Point: Should suppliers be partners?

Vantage Point: Should suppliers be partners?

A foundational premise of agency-of-record and preferred-provider relationships has a fatal flaw

Vantage Point: Hepatitis C

Vantage Point: Hepatitis C

As it became evident that a large HCV+ cohort would likely need medical intervention, pharma responded

Vantage Point: Correct Terminology

Vantage Point: Correct Terminology

In 2012, the phrase "pharmaceutical marketing research" seems a little wrong

Vantage Point: Marketing and Drug Development

Vantage Point: Marketing and Drug Development

Marketing continues to be a secondary consideration in the development process

Vantage Point: Addressing 'opportunity leakage'

Vantage Point: Addressing 'opportunity leakage'

Prescribing remains important, but it's half the picture: pharma's ultimate customer is the patient

Vantage Point: Strategies for sales reps

Vantage Point: Strategies for sales reps

These steps can equip sales teams to work around limited access, bring value to oncologists and increase sales

Vantage Point: The Affordable Care Act

Vantage Point: The Affordable Care Act

Most stakeholders have little or no knowledge of the Act's 1,500 pages of specifics or their implications

Vantage Point: Recruiting the right patients for clinical trials

Vantage Point: Recruiting the right patients for clinical trials

In a fast-changing industry, a constant is how the limited number of patients for trials hinders drug development

Vantage Point: multicultural marketing

Vantage Point: multicultural marketing

When it comes to multicultural marketing, a patient-centered focus is still an evolving, nascent notion in pharma

Vantage Point: The Role of Social Media

Vantage Point: The Role of Social Media

As we consider the role of social media in healthcare marketing, there is likely no other measure more important than "clout."

Vantage Point: How social media can make an impact

Vantage Point: How social media can make an impact

Social media can have a far-reaching impact on study time, costs, quality and outcomes

Vantage Point: Fixing What's Broken in Pharma

Vantage Point: Fixing What's Broken in Pharma

A survey shows that many leaders think "the current commercial pharmaceutical model is broken"

Vantage Point: Healthcare's new promotional target

Vantage Point: Healthcare's new promotional target

Some analysts predict that over half of all calls by 2015 will be fielded by NPs, PAs and others

Vantage Point: What 2012 could bring

Vantage Point: What 2012 could bring

Wrapping up what was remarkable about the past year, and pondering how the New Year will be the same and/or different.

Vantage Point: Comparative Effectiveness Research

Vantage Point: Comparative Effectiveness Research

Comparative Effectiveness Research (CER) is becomimg a key element in assessing the value of healthcare products.

Vantage Point: Behavioral Economics

How pharmaceutical marketing research could benefit from understanding behavioral economics.

Vantage Point: Introducing the "CreaSearchers"

A new kind of "soft" researcher may be in increasing demand: a "CreaSearcher," someone who combines creative and qualitative research, bridging what has traditionally been a gap between the two.

Vantage Point

Over the last few months, I've been thinking a lot about trends in pharmaceutical marketing research.

Vantage Point

The budgets and the personnel devoted to the generation of customer insight are shrinking, putting more pressure on market research functions to deliver value supportive of business priorities.

Vantage Point

Understanding and measuring what motivates behavior is a central goal for many pharmaceutical market research projects.

Vantage Point

I've had an epiphany! I have come to believe that much of pharma marketing research is conducted with the wrong respondents.

Vantage Point

While industries like retail, hospitality and technology have endeavored to make customer experience a primary driver for innovation, the same cannot be said for most healthcare delivery systems.

Vantage Point

The last two years saw controversy regarding the drug approval process.

Email Newsletters